Search results
Here are 7 things Arizonans need to know about the new KP.3 variant of COVID-19
AZCentral | The Arizona Republic via Yahoo News· 2 days agoA new variant of COVID-19 called KP.3 is on the rise in the U.S. and has been detected in Arizona. The variant of the SARS-CoV-2 virus ...
Past COVID infections may help protect against certain colds
WJZY via Yahoo News· 24 hours agoThese vaccines, he said, are “still your best defense against severe COVID-19 infection,...
Clinical trial shows 15-day Paxlovid regimen safe but adds no clear benefit for long COVID
Medical Xpress· 6 days agoIn a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
Medical Xpress· 1 day agoIf you've been sick with COVID-19, you may have some protection against certain versions of the...
Past COVID-19 infection may protect people against some common colds
Euronews via Yahoo News· 18 hours agoThese vaccines, he said, are “still your best defence against severe COVID-19 infection,...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
San Francisco Chronicle· 1 day agoIf you’ve been sick with COVID-19, you may have some protection against certain versions of the...
Another COVID vaccine? Yes, and here’s why
Denver Post· 2 days agoLast year’s shot isn’t holding up. Protection against both infection and severe illness is waning. “Effectiveness has decreased, as the time since...
What causes long COVID? Case builds for rogue antibodies
Nature· 1 day agoStudy finds that antibodies from people with the debilitating condition trigger similar symptoms in...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 3 days agoAn experimental two-in-one vaccine triggered strong immune responses against both the flu and SARS-CoV-2, the virus behind COVID-19, ...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 14 hours ago“Today’s vaccine efficacy data are consistent with the previously announced immunogenicity results...